QURE
Price
$14.25
Change
-$0.14 (-0.97%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
778.17M
19 days until earnings call
SNGX
Price
$2.15
Change
+$0.08 (+3.86%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
6.52M
Ad is loading...

QURE vs SNGX

Header iconQURE vs SNGX Comparison
Open Charts QURE vs SNGXBanner chart's image
uniQure
Price$14.25
Change-$0.14 (-0.97%)
Volume$15.36K
Capitalization778.17M
Soligenix
Price$2.15
Change+$0.08 (+3.86%)
Volume$3.98K
Capitalization6.52M
QURE vs SNGX Comparison Chart
Loading...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QURE vs. SNGX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QURE is a Buy and SNGX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (QURE: $14.39 vs. SNGX: $2.07)
Brand notoriety: QURE and SNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QURE: 98% vs. SNGX: 20%
Market capitalization -- QURE: $778.17M vs. SNGX: $6.52M
QURE [@Biotechnology] is valued at $778.17M. SNGX’s [@Biotechnology] market capitalization is $6.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QURE’s FA Score shows that 0 FA rating(s) are green whileSNGX’s FA Score has 1 green FA rating(s).

  • QURE’s FA Score: 0 green, 5 red.
  • SNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both QURE and SNGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QURE’s TA Score shows that 4 TA indicator(s) are bullish while SNGX’s TA Score has 5 bullish TA indicator(s).

  • QURE’s TA Score: 4 bullish, 5 bearish.
  • SNGX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNGX is a better buy in the short-term than QURE.

Price Growth

QURE (@Biotechnology) experienced а +53.25% price change this week, while SNGX (@Biotechnology) price change was +0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

QURE is expected to report earnings on Jul 31, 2025.

SNGX is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($778M) has a higher market cap than SNGX($6.52M). QURE YTD gains are higher at: -18.516 vs. SNGX (-23.191). SNGX has higher annual earnings (EBITDA): -8.06M vs. QURE (-160.74M). QURE has more cash in the bank: 368M vs. SNGX (9.84M). SNGX has less debt than QURE: SNGX (2.2M) vs QURE (66.1M). QURE has higher revenues than SNGX: QURE (27.1M) vs SNGX (0).
QURESNGXQURE / SNGX
Capitalization778M6.52M11,940%
EBITDA-160.74M-8.06M1,994%
Gain YTD-18.516-23.19180%
P/E RatioN/AN/A-
Revenue27.1M0-
Total Cash368M9.84M3,740%
Total Debt66.1M2.2M3,000%
FUNDAMENTALS RATINGS
QURE vs SNGX: Fundamental Ratings
QURE
SNGX
OUTLOOK RATING
1..100
251
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
3588
P/E GROWTH RATING
1..100
88100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNGX's Valuation (31) in the Biotechnology industry is somewhat better than the same rating for QURE (74). This means that SNGX’s stock grew somewhat faster than QURE’s over the last 12 months.

SNGX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as QURE (100). This means that SNGX’s stock grew similarly to QURE’s over the last 12 months.

SNGX's SMR Rating (96) in the Biotechnology industry is in the same range as QURE (98). This means that SNGX’s stock grew similarly to QURE’s over the last 12 months.

QURE's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for SNGX (88). This means that QURE’s stock grew somewhat faster than SNGX’s over the last 12 months.

QURE's P/E Growth Rating (88) in the Biotechnology industry is in the same range as SNGX (100). This means that QURE’s stock grew similarly to SNGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QURESNGX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REPL8.830.12
+1.38%
Replimune Group
ICFI84.52-0.64
-0.75%
ICF International
ELMD22.81-0.18
-0.78%
Electromed
GFI22.20-1.19
-5.09%
Gold Fields Ltd
GDC2.07-0.16
-7.17%
GD Culture Group Limited

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with CMRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
N/A
CMRX - QURE
52%
Loosely correlated
N/A
NAMS - QURE
52%
Loosely correlated
+2.86%
HOOK - QURE
44%
Loosely correlated
+4.00%
AXON - QURE
42%
Loosely correlated
+3.82%
ABSI - QURE
38%
Loosely correlated
-0.47%
More

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been loosely correlated with THAR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNGX jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
+0.24%
THAR - SNGX
46%
Loosely correlated
+3.03%
QURE - SNGX
37%
Loosely correlated
N/A
VRAX - SNGX
36%
Loosely correlated
+6.34%
ATHA - SNGX
31%
Poorly correlated
+4.91%
VNDA - SNGX
30%
Poorly correlated
-1.81%
More